CVRx (CVRX) Competitors $6.02 +0.08 (+1.35%) As of 01:20 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. NPCE, TCMD, MDXG, KIDS, and BBNXShould you buy CVRx stock or one of its competitors? MarketBeat compares CVRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CVRx include NeuroPace (NPCE), Tactile Systems Technology (TCMD), MiMedx Group (MDXG), OrthoPediatrics (KIDS), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. CVRX vs. NPCECVRX vs. TCMDCVRX vs. MDXGCVRX vs. KIDSCVRX vs. BBNXHow does CVRx compare to NeuroPace?NeuroPace (NASDAQ:NPCE) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings. Does the media refer more to NPCE or CVRX? In the previous week, NeuroPace had 13 more articles in the media than CVRx. MarketBeat recorded 18 mentions for NeuroPace and 5 mentions for CVRx. NeuroPace's average media sentiment score of 0.65 beat CVRx's score of 0.54 indicating that NeuroPace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 0 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in NPCE or CVRX? 78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 20.5% of NeuroPace shares are owned by insiders. Comparatively, 13.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer NPCE or CVRX? NeuroPace presently has a consensus target price of $18.83, indicating a potential upside of 18.75%. CVRx has a consensus target price of $11.50, indicating a potential upside of 91.03%. Given CVRx's stronger consensus rating and higher probable upside, analysts plainly believe CVRx is more favorable than NeuroPace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.88CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00 Is NPCE or CVRX more profitable? NeuroPace has a net margin of -21.67% compared to CVRx's net margin of -89.14%. NeuroPace's return on equity of -108.20% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-21.67% -108.20% -18.50% CVRx -89.14%-120.76%-48.38% Which has preferable valuation and earnings, NPCE or CVRX? NeuroPace has higher revenue and earnings than CVRx. NeuroPace is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$99.99M5.41-$21.47M-$0.65N/ACVRx$59.07M2.70-$53.31M-$2.02N/A Which has more volatility and risk, NPCE or CVRX? NeuroPace has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, CVRx has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. SummaryNeuroPace beats CVRx on 13 of the 16 factors compared between the two stocks.How does CVRx compare to Tactile Systems Technology?Tactile Systems Technology (NASDAQ:TCMD) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations. Does the media favor TCMD or CVRX? In the previous week, CVRx had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 5 mentions for CVRx and 3 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.55 beat CVRx's score of 0.54 indicating that Tactile Systems Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tactile Systems Technology 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, TCMD or CVRX? Tactile Systems Technology has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, CVRx has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Is TCMD or CVRX more profitable? Tactile Systems Technology has a net margin of 5.91% compared to CVRx's net margin of -89.14%. Tactile Systems Technology's return on equity of 9.70% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets Tactile Systems Technology5.91% 9.70% 7.53% CVRx -89.14%-120.76%-48.38% Do analysts rate TCMD or CVRX? Tactile Systems Technology currently has a consensus price target of $38.60, indicating a potential upside of 59.24%. CVRx has a consensus price target of $11.50, indicating a potential upside of 91.03%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Tactile Systems Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tactile Systems Technology 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in TCMD or CVRX? 83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 13.9% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has preferable valuation and earnings, TCMD or CVRX? Tactile Systems Technology has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTactile Systems Technology$329.52M1.66$19.09M$0.8827.55CVRx$59.07M2.70-$53.31M-$2.02N/A SummaryTactile Systems Technology beats CVRx on 10 of the 17 factors compared between the two stocks.How does CVRx compare to MiMedx Group?MiMedx Group (NASDAQ:MDXG) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Do institutionals & insiders have more ownership in MDXG or CVRX? 79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 2.5% of MiMedx Group shares are owned by insiders. Comparatively, 13.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor MDXG or CVRX? In the previous week, CVRx had 1 more articles in the media than MiMedx Group. MarketBeat recorded 5 mentions for CVRx and 4 mentions for MiMedx Group. CVRx's average media sentiment score of 0.54 beat MiMedx Group's score of 0.00 indicating that CVRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate MDXG or CVRX? MiMedx Group presently has a consensus target price of $8.50, suggesting a potential upside of 133.84%. CVRx has a consensus target price of $11.50, suggesting a potential upside of 91.03%. Given MiMedx Group's higher possible upside, equities research analysts plainly believe MiMedx Group is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more volatility and risk, MDXG or CVRX? MiMedx Group has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, CVRx has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Is MDXG or CVRX more profitable? MiMedx Group has a net margin of 7.88% compared to CVRx's net margin of -89.14%. MiMedx Group's return on equity of 21.03% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group7.88% 21.03% 15.92% CVRx -89.14%-120.76%-48.38% Which has stronger earnings & valuation, MDXG or CVRX? MiMedx Group has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$418.63M1.29$48.58M$0.2018.18CVRx$59.07M2.70-$53.31M-$2.02N/A SummaryMiMedx Group beats CVRx on 11 of the 17 factors compared between the two stocks.How does CVRx compare to OrthoPediatrics?CVRx (NASDAQ:CVRX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has higher earnings & valuation, CVRX or KIDS? OrthoPediatrics has higher revenue and earnings than CVRx. OrthoPediatrics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$59.07M2.70-$53.31M-$2.02N/AOrthoPediatrics$236.35M1.98-$39.65M-$1.68N/A Do analysts prefer CVRX or KIDS? CVRx presently has a consensus price target of $11.50, suggesting a potential upside of 91.03%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 34.23%. Given CVRx's stronger consensus rating and higher probable upside, research analysts clearly believe CVRx is more favorable than OrthoPediatrics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00OrthoPediatrics 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.82 Is CVRX or KIDS more profitable? OrthoPediatrics has a net margin of -16.31% compared to CVRx's net margin of -89.14%. OrthoPediatrics' return on equity of -7.01% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-89.14% -120.76% -48.38% OrthoPediatrics -16.31%-7.01%-4.86% Do institutionals and insiders have more ownership in CVRX or KIDS? 75.3% of CVRx shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 13.9% of CVRx shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, CVRX or KIDS? CVRx has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Does the media refer more to CVRX or KIDS? In the previous week, CVRx had 3 more articles in the media than OrthoPediatrics. MarketBeat recorded 5 mentions for CVRx and 2 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.07 beat CVRx's score of 0.54 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOrthoPediatrics beats CVRx on 10 of the 17 factors compared between the two stocks.How does CVRx compare to Beta Bionics?CVRx (NASDAQ:CVRX) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership. Which has stronger valuation and earnings, CVRX or BBNX? CVRx has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$59.07M2.70-$53.31M-$2.02N/ABeta Bionics$100.25M4.13-$73.20M-$1.51N/A Do analysts recommend CVRX or BBNX? CVRx presently has a consensus target price of $11.50, suggesting a potential upside of 91.03%. Beta Bionics has a consensus target price of $20.00, suggesting a potential upside of 115.24%. Given Beta Bionics' higher possible upside, analysts clearly believe Beta Bionics is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00Beta Bionics 1 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.67 Does the media prefer CVRX or BBNX? In the previous week, CVRx had 2 more articles in the media than Beta Bionics. MarketBeat recorded 5 mentions for CVRx and 3 mentions for Beta Bionics. CVRx's average media sentiment score of 0.54 beat Beta Bionics' score of 0.04 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of CVRX or BBNX? 75.3% of CVRx shares are owned by institutional investors. 13.9% of CVRx shares are owned by company insiders. Comparatively, 5.3% of Beta Bionics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, CVRX or BBNX? CVRx has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.29, meaning that its share price is 229% more volatile than the broader market. Is CVRX or BBNX more profitable? Beta Bionics has a net margin of -60.27% compared to CVRx's net margin of -89.14%. Beta Bionics' return on equity of -23.00% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-89.14% -120.76% -48.38% Beta Bionics -60.27%-23.00%-20.55% SummaryBeta Bionics beats CVRx on 9 of the 17 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition ExportMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$159.75M$6.90B$6.28B$12.14BDividend YieldN/A1.75%2.80%5.32%P/E Ratio-2.9849.5020.6125.12Price / Sales2.7083.21581.1392.21Price / CashN/A24.4327.4837.30Price / Book4.016.589.746.62Net Income-$53.31M$158.81M$3.55B$335.39M7 Day Performance14.23%-0.93%-1.79%-1.72%1 Month Performance-18.21%-5.33%-3.65%-1.61%1 Year Performance-12.12%-4.17%29.85%27.79% CVRx Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx3.4554 of 5 stars$6.02+1.3%$11.50+91.0%-6.3%$159.75M$59.07MN/A160Analyst UpgradeGap DownNPCENeuroPace3.5376 of 5 stars$15.97+1.9%$18.67+16.9%-8.6%$544.73M$99.99MN/A170Earnings ReportAnalyst RevisionTCMDTactile Systems Technology4.3718 of 5 stars$23.88-0.1%$38.60+61.6%+127.4%$538.73M$329.52M27.141,086MDXGMiMedx Group3.2737 of 5 stars$3.58+0.4%$8.50+137.8%-49.1%$532.50M$418.63M17.88870KIDSOrthoPediatrics3.6323 of 5 stars$17.59+2.4%$24.44+39.0%-21.4%$450.94M$236.35MN/A200 Related Companies and Tools Related Companies NPCE Competitors TCMD Competitors MDXG Competitors KIDS Competitors BBNX Competitors DCTH Competitors CLPT Competitors CV Competitors TLSI Competitors SI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
